Use of at least one EP2 receptor antagonist including (a) derived from indazol and (b) at least one COX inhibitor selected from indomethacina, meloxicam or piroxicam for demand side contraception.

摘要

Use of a Pharmaceutical composition comprising a) at least one Derivative of EP2 receptor antagonist indazol and (b) at least one chosen of Cox inhibitor indomethacin, diclofenac, piroxicam and meloxicam, for contraception on demand.